Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2013
Home
2013
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Settlement of Advangen Inc Acquisition Completed
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Change of Director’s Interest Notice
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Change of Director’s Interest Notice
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Appointment of Company Secretary
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Fujikura Exercises Option To License Cellmid’s Diagnostics
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Release of Shares from Voluntary Escrow
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Appendix 4C – quarterly
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Cellmid Collaborates on Early Diagnosis of Colorectal Cancer
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Cellmid Received Pacific Edge Milestone Shares
Prev page
1
2
3
4
5
6
Next page
